Judy Ho

Judy Ho (commonly known as Dr. Judy Ho or Dr. Judy) is a Taiwanese-American clinical psychologist.

Ho appears on national television and radio broadcasts as a psychology expert, panelist, narrator and host. hosted the CBS syndicated talk show ''Face The Truth'' (2018) alongside Vivica Fox, was panelist on more than 200 episodes of ''The Dr. Drew Show'' from 2013 to 2016, and co-hosted Season 12, 13, and 14 of ''The Doctors.''

Ho maintains a private practice based in Los Angeles, California, while working as a tenured associate professor of psychology at Pepperdine University's Graduate School of Education and Psychology, where she has taught since 2010. Provided by Wikipedia
Showing 1 - 2 results of 2 for search 'Judy Ho', query time: 0.02s Refine Results
  1. 1
    PB2221: AN OPEN-LABEL, PHASE 1/1B STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS AND CLINICAL ACTIVITY OF IMETELSTAT IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS: IMPROVEMF

    PB2221: AN OPEN-LABEL, PHASE 1/1B STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS AND CLINICAL ACTIVITY OF IMETELSTAT IN COMBINATION WITH RUXOLITINIB IN PATIENTS W... by Andrew Kuykendall, Terrence Bradley, Rami S. Komrokji, Tymara Berry, Souria Dougherty, Laurie Sherman, Lixian Peng, Fei Huang, Ying Wan, Vivian Rodolf, Judy Ho, Shyamala Navada, John Mascarenhas

    Published 2023-08-01
    Get full text
    Article
  2. 2
    PB2225: A RANDOMIZED OPEN-LABEL, PHASE 3 STUDY OF IMETELSTAT VS BEST AVAILABLE THERAPY IN INTERMEDIATE-2 OR HIGH-RISK MYELOFIBROSIS RELAPSED/REFRACTORY TO JAK INHIBITOR (IMPACTMF)

    PB2225: A RANDOMIZED OPEN-LABEL, PHASE 3 STUDY OF IMETELSTAT VS BEST AVAILABLE THERAPY IN INTERMEDIATE-2 OR HIGH-RISK MYELOFIBROSIS RELAPSED/REFRACTORY TO JAK INHIBITOR (IMPACTMF) by John Mascarenhas, Claire Harrison, Jean-Jacques Kiladjian, Katja Sockel, Alessandro Vannucchi, Tymara Berry, Denise Redding, Laurie Sherman, Souria Dougherty, Lixian Peng, Libo Sun, Fei Huang, Ying Wan, Vivian Rodolf, Judy Ho, Shyamala Navada, Rami S. Komrokji

    Published 2023-08-01
    Get full text
    Article

Search Tools: